- Home
- QMMM vs LYEL Comparison
QMMM vs LYEL Comparison
Compare QMMM & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMMM
- LYEL
- Stock Information
- Founded
- QMMM 2005
- LYEL 2018
- Country
- QMMM Hong Kong
- LYEL United States
- Employees
- QMMM N/A
- LYEL N/A
- Industry
- QMMM
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- QMMM
- LYEL Health Care
- Exchange
- QMMM NYSE
- LYEL Nasdaq
- Market Cap
- QMMM 196.2M
- LYEL 203.9M
- IPO Year
- QMMM 2024
- LYEL 2021
- Fundamental
- Price
- QMMM $0.85
- LYEL $0.58
- Analyst Decision
- QMMM
- LYEL Sell
- Analyst Count
- QMMM 0
- LYEL 2
- Target Price
- QMMM N/A
- LYEL $1.00
- AVG Volume (30 Days)
- QMMM 1.0M
- LYEL 1.1M
- Earning Date
- QMMM 02-21-2025
- LYEL 02-26-2025
- Dividend Yield
- QMMM N/A
- LYEL N/A
- EPS Growth
- QMMM N/A
- LYEL N/A
- EPS
- QMMM N/A
- LYEL N/A
- Revenue
- QMMM $3,510,653.00
- LYEL $63,000.00
- Revenue This Year
- QMMM N/A
- LYEL N/A
- Revenue Next Year
- QMMM N/A
- LYEL N/A
- P/E Ratio
- QMMM N/A
- LYEL N/A
- Revenue Growth
- QMMM 20.09
- LYEL N/A
- 52 Week Low
- QMMM $0.54
- LYEL $0.55
- 52 Week High
- QMMM $13.00
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- QMMM N/A
- LYEL 34.70
- Support Level
- QMMM N/A
- LYEL $0.55
- Resistance Level
- QMMM N/A
- LYEL $0.62
- Average True Range (ATR)
- QMMM 0.00
- LYEL 0.04
- MACD
- QMMM 0.00
- LYEL 0.01
- Stochastic Oscillator
- QMMM 0.00
- LYEL 14.24
About QMMM QMMM HOLDINGS LIMITED
QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly-owned subsidiaries. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.